Details

Univ.-Prof. Mag. Dr. Gerhard Ecker

T: +43-1-4277-55110

gerhard.f.ecker@univie.ac.at

http://pharminfo.univie.ac.at

Consultation hours: Wed 14:00 - 15:00, 2E405 or online, registration per E-mail at latest till Friday the week before

Winter term 2024

301800 VO MPM 1 - Lecture Course: Fundamentals of DNA replication and sources of DNA damage, - including defective DNA repair mechanisms, in the context of signature diseases

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321005 VO Grundlagen der physikalischen Chemie - B3

321007 VO Statistik für PharmazeutInnen - BA7 - B3

321028 VO Pharmazeutische Chemie 1 - B15

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322026 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13

323003 VO Basics of Drug Discovery - MPS2

323005 VO Preclinical Drug Development - MPS4

Summer term 2024

301817 UE MPM 6 - Practical Course: Pharmacoinformatics and structure-based drug design

321029 VO Pharmazeutische Chemie 2 - B15

322005 VO (Bio)pharmazeutika mit Wirkung auf das Herz-Kreislauf System - M4

322006 VO (Bio)pharmazeutika mit Wirkung auf das Nervensystem - M5

322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13

323101 VU Pharmacoinformatics - MPS5

323102 VU Pharmacoinformatics Practical Course - MPS5

Winter term 2023

301800 VO MPM 1 - Lecture Course: Fundamentals of DNA replication and sources of DNA damage, - including defective DNA repair mechanisms, in the context of signature diseases

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321005 VO Grundlagen der physikalischen Chemie - B3

321028 VO Pharmazeutische Chemie 1 - B15

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13

323003 VO Basics of Drug Discovery - MPS2

323005 VO Preclinical Drug Development - MPS4

950210 VO VO Einführung in die Klinische Pharmazie

Li, E, Boujeddaine, N, Houtman, MJC, Maas, Sluijter, , Ecker, G , Weinzinger, A, van Ham, W & van der Heyden, M 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology. <https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.17377>

Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599

Granulo, N, Sosnin, S , Digles, D & Ecker, GF 2024, 'The macrocycle inhibitor landscape of SLC‐transporter', Molecular Informatics, vol. 43, no. 5, e202300287. https://doi.org/10.1002/minf.202300287

Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S , Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d

Ferrada, E, Wiedmer, T, Wang, WA, Frommelt, F, Steurer, B, Klimek, C, Lindinger, S, Osthushenrich, T, Garofoli, A, Brocchetti, S, Bradberry, S, Huang, J, MacNamara, A, Scarabottolo, L, Ecker, GF, Malarstig, A & Superti-Furga, G 2024, 'Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8', Journal of Molecular Biology, vol. 436, no. 2, 168383. https://doi.org/10.1016/j.jmb.2023.168383

Helmke, P, Füzi, B & Ecker, GF 2024, 'Bioactivity descriptors for in vivo toxicity prediction: now and the future', Expert Opinion on Drug Metabolism and Toxicology, vol. 20, no. 7, pp. 541-543. https://doi.org/10.1080/17425255.2024.2334308

Grandits, M & Ecker, GF 2024, 'Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling', Current drug research reviews, vol. 16, no. 2, pp. 81-93. https://doi.org/10.2174/2589977515666230508123041

Smajić, A, Grandits, M & Ecker, GF 2023, 'Privacy-preserving techniques for decentralized and secure machine learning in drug discovery', Drug Discovery Today, vol. 28, no. 12, 103820, pp. 1-8. https://doi.org/10.1016/j.drudis.2023.103820

Grillberger, K, Cöllen, E, Trivisani, CI, Blum, J, Leist, M & Ecker, G 2023, 'Structural Insights into Neonicotinoids and N-Unsubstituted Metabolites on Human nAChRs by Molecular Docking, Dynamics Simulations, and Calcium Imaging', International Journal of Molecular Sciences, vol. 24, no. 17, 13170. https://doi.org/10.3390/ijms241713170

Smajić, A, Rami, I, Sosnin, S & Ecker, GF 2023, 'Identifying Differences in the Performance of Machine Learning Models for Off-Targets Trained on Publicly Available and Proprietary Data Sets', Chemical Research in Toxicology, vol. 36, no. 8, pp. 1300-1312. https://doi.org/10.1021/acs.chemrestox.3c00042

Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Sanz, F, Pognan, F, Steger-Hartmann, T, Díaz, C, Asakura, S, Amberg, A, Bécourt-Lhote, N, Blomberg, N, Bosc, N, Briggs, K, Bringezu, F, Brulle-Wohlhueter, C, Brunak, S, Bueters, R, Callegaro, G, Capella-Gutierrez, S, Centeno, E, Corvi, J, Cronin, MTD, Drew, P, Duchateau-Nguyen, G, Ecker, GF, Escher, S, Felix, E, Ferreiro, M, Frericks, M, Furlong, LI, Geiger, R, George, C, Ivanov-Draganov, D, Kilgour-Christie, J, Kiziloren, T, Kors, JA, Koyama, N, Kreuchwig, A, Leach, AR, Mayer, M-A, Monecke, P, Muster, W, Nakazawa, CM, Nicholson, G, Parry, R, Piñero, J, Oberhauser, N, Ramírez-Anguita, JM, Rodrigo, A, Smajic, A, Schaefer, M, Schieferdecker, S, Soininen, I, Terricabras, E, Trairatphisan, P, Turner, SC, Valencia, A, van de Water, B, van der Lei, JL, van Mulligen, EM, Vock, E & Wilkinson, D 2023, 'eTRANSAFE: data science to empower translational safety assessment', Nature Reviews. Drug Discovery, vol. 22, no. 8, pp. 605-606. https://doi.org/10.1038/d41573-023-00099-5

Füzi, B, Mathai, N, Kirchmair, J & Ecker, GF 2023, 'Toxicity prediction using target, interactome, and pathway profiles as descriptors', Toxicology Letters, vol. 381, pp. 20-26. https://doi.org/10.1016/j.toxlet.2023.04.005

Huang, J & Ecker, G 2023, 'A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance', Molecules, vol. 28, no. 2, 495, pp. 494. https://doi.org/10.3390/molecules28020495

van der Noord, VE, van der Stel, W, Louwerens, G, Verhoeven, D, Kuiken, HJ, Lieftink, C, Grandits, M , Ecker, GF, Beijersbergen, RL, Bouwman, P, Le Dévédec, SE & van de Water, B 2023, 'Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors', Breast Cancer Research, vol. 25, no. 1, 51, pp. 51. https://doi.org/10.1186/s13058-023-01648-x

Schrempf, A, Bernardo, S, Arasa Verge, EA, Ramirez Otero, MA, Wilson, J, Kirchhofer, D, Timelthaler, G, Ambros, AM, Kaya, A, Wieder, M, Ecker, GF, Winter, GE, Costanzo, V & Loizou, JI 2022, 'POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells', Cell Reports, vol. 41, no. 9, 111716. https://doi.org/10.1016/j.celrep.2022.111716

Smajic, A , Grandits, M & Ecker, GF 2022, 'Using Jupyter Notebooks for re-training machine learning models', Journal of Cheminformatics, vol. 14, no. 1, 54. https://doi.org/10.1186/s13321-022-00635-2

Naga, D, Parrott, N, Ecker, GF & Olivares-Morales, A 2022, 'Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery', Molecular Pharmaceutics, vol. 19, no. 7, pp. 2203-2216. https://doi.org/10.1021/acs.molpharmaceut.2c00040

Decker, S, Taschauer, A, Geppl, E, Pirhofer, V, Schauer, M, Pöschl, S, Kopp, F, Richter, L, Ecker, GF , Sami, H & Ogris, M 2022, 'Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery', European Journal of Pharmaceutics and Biopharmaceutics, vol. 176, pp. 211-221. https://doi.org/10.1016/j.ejpb.2022.05.004

Füzi, B, Malik-Sheriff, RS, Manners, EJ, Hermjakob, H & Ecker, GF 2022, 'KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI case study', Journal of Cheminformatics, vol. 14, no. 1, 37. https://doi.org/10.1186/s13321-022-00615-6